NPF News

Long-term use of aspirin may reduce risk for pancreatic cancer

Categories: News, NPF News, Other

Continual use of low-dose or regular-dose aspirin may cut a person’s risk of developing pancreatic cancer in half, a Yale School of Public Health and Yale Cancer Center study has found. Further, the degree of protection may grow the longer one takes the aspirin. The study appears in the journal Cancer Epidemiology, Biomarkers & Prevention. …

Read More

ChiRhoClin announces the availability of ChiRhoStim

Categories: News, NPF News, Other

ChiRhoClin, Inc. announces the availability of ChiRhoStim® (Human Secretin for injection) to the medical community. (Burtonsville, Maryland) ChiRhoStim® (Human Secretin for injection) is now commercially available to the medical community.  ChiRhoStim® batch #0636149 was manufactured in June 2013 in a new manufacturing facility and has met all product release and sterility tests. This new facility …

Read More

Easing the Pain of Chronic Pancreatitis

Categories: NPF News, Other, Uncategorized
Patients with chronic pancreatitis often face severe, unrelenting pain with little or no relief. There is no cure for this progressive disease but a new surgical treatment offered at Dartmouth-Hitchcock offers hope to patients like Jennifer Bowen, who once thought a normal life would never be possible.  To view Jennifer’s story, please visit here.   …

Read More

Hackensack Symposium Explores Sharp Rise in Cases of Pancreas Cancer

Categories: News, NPF News, Other

The inaugural event for the New Jersey Chapter of the National Pancreas Foundation was held this past weekend at the John Theurer Cancer Center.  The Dr. John M. Totaro Pancreas Cancer Symposium brought together numerous experts to discuss topics ranging from advanced screening of pancreas cancer to palliative care and nutrition. John M. Totaro III, for …

Read More

May is National Cancer Research Month

Categories: News, NPF News, Other

Don’t forget to mark this month as National Cancer Research Month! The NPF is proud to support research in the field of pancreas cancer. We hope that the near future holds improvements in both early detection and treatment options.